{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:21:38Z","timestamp":1791872498710,"version":"4.3.4"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Various factors hinder older adults from discontinuing benzodiazepine receptor agonists (BZRAs). Identifying and prioritising these barriers is essential for designing effective interventions to discontinue BZRAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify barriers to BZRA discontinuation among older adults and factors associated with their willingness to reduce or stop use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional survey was conducted among adults 65+ using BZRA for sleep problems, recruited from hospitals across six European countries. Barriers were identified via a 27-item questionnaire grounded in the Theoretical Domains Framework (TDF), which systematically identifies individual and contextual determinants of behaviour. Responses were analysed using descriptive statistics. Multivariable logistic regressions identified factors associated with patients\u2019 willingness to reduce or stop BZRA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 183 participants, 59.1% were willing to reduce and 42.7% to stop BZRA if recommended by their doctor. Half understood why discontinuation is necessary. Barriers were present for most participants across multiple TDF domains. They included: high satisfaction with BZRA, perceived low risk of side effects, limited coping skills or ability to stop, fear of discontinuation and lack of support from physicians or social networks. Higher scores in the TDF domains of Goals, Emotion and Social Influences were associated with greater willingness to reduce BZRA. These domains and Reinforcement, Environmental context and resources were also linked to a greater willingness to stop.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight the opportunities and challenges of discontinuing BZRA in older adults. While half know the need to discontinue and are willing to try, future interventions must address pervasive barriers across many behavioural domains.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afaf342","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:51:12Z","timestamp":1763470272000},"source":"Crossref","is-referenced-by-count":4,"title":["Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe"],"prefix":"10.1093","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0209-1879","authenticated-orcid":false,"given":"Vladyslav","family":"Shapoval","sequence":"first","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain , Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"de Saint Hubert","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, CHU UCL Namur , Yvoir ,","place":["Belgium"]},{"name":"Institute of Health and Society (IRSS), Universit\u00e9 Catholique de Louvain , Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"P\u00e9tein","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain , Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Viaud","sequence":"additional","affiliation":[{"name":"Pharmacy Department, CHU UCL Namur , Yvoir ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokandji","family":"Adda","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain , Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8325-8784","authenticated-orcid":false,"given":"Carole Elodie","family":"Aubert","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Inselspital University Hospital Bern , Bern ,","place":["Switzerland"]},{"name":"Institute of Primary Health Care (BIHAM), University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Mooser","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Inselspital University Hospital Bern , Bern ,","place":["Switzerland"]},{"name":"Institute of Primary Health Care (BIHAM), University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagioula","family":"Tsoutsi","sequence":"additional","affiliation":[{"name":"Sleep Research Unit , First Department of Psychiatry, Eginition Hospital, Medical School, National & Kapodistrian University of Athens, Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Dikeos","sequence":"additional","affiliation":[{"name":"Sleep Research Unit , First Department of Psychiatry, Eginition Hospital, Medical School, National & Kapodistrian University of Athens, Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Fern\u00e1ndez","family":"Maldonado","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3 Salut i Envelliment Universit\u00e9 autonome de Barcelone, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Manuel Perez","family":"Castejon","sequence":"additional","affiliation":[{"name":"Badalona Serveis Assistencials , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wichniak","sequence":"additional","affiliation":[{"name":"Third Department of Psychiatry, Institute of Psychiatry and Neurology , Warsaw ,","place":["Poland"]},{"name":"Department of Clinical Neurophysiology, Sleep Medicine Centre, Institute of Psychiatry and Neurology , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Gustavsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurophysiology, Sleep Medicine Centre, Institute of Psychiatry and Neurology , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgeir Bruun","family":"Wyller","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Oslo University Hospital , Oslo ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Callegari","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Oslo University Hospital , Oslo ,","place":["Norway"]},{"name":"Department of Old Age Psychiatry, Ostfold Hospital Trust , Gr\u00e5lum ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8015-8243","authenticated-orcid":false,"given":"Jeremy","family":"Grimshaw","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research, Ottawa Hospital Research Institute , Ottawa, Ontario ,","place":["Canada"]},{"name":"Department of Medicine, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2132-0703","authenticated-orcid":false,"given":"Justin","family":"Presseau","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research, Ottawa Hospital Research Institute , Ottawa, Ontario ,","place":["Canada"]},{"name":"School of Epidemiology and Public Health, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Patey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Quality and Safety, IWK Health Centre , Halifax, Nova Scotia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Corachan","sequence":"additional","affiliation":[{"name":"International Patient Advisory Board (iPAC), Universit\u00e9 Catholique de Louvain , Louvain-la-Neuve ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-8093","authenticated-orcid":false,"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain , Brussels ,","place":["Belgium"]},{"name":"Institute of Health and Society (IRSS), Universit\u00e9 Catholique de Louvain , Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain , Brussels ,","place":["Belgium"]},{"name":"Pharmacy Department, CHU UCL Namur , Yvoir ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2025120408275253600_ref1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.sleep.2024.03.040","article-title":"Worldwide prevalence of sleep problems in community-dwelling older adults: A systematic review and meta-analysis","volume":"119","author":"Canever","year":"2024","journal-title":"Sleep Med"},{"key":"2025120408275253600_ref2","doi-asserted-by":"crossref","first-page":"heartjnl-2024-325362","DOI":"10.1136\/heartjnl-2024-325362","article-title":"Insomnia symptom trajectories and incident cardiovascular disease in older adults: A longitudinal cohort study","volume":"0","author":"Huang","year":"2025","journal-title":"Heart"},{"key":"2025120408275253600_ref3","doi-asserted-by":"crossref","first-page":"zsaa063","DOI":"10.1093\/sleep\/zsaa063","article-title":"Role of persistent and worsening sleep disturbance in depression remission and suicidal ideation among older primary care patients: The PROSPECT study","volume":"43","author":"Gallo","year":"2020","journal-title":"Sleep"},{"key":"2025120408275253600_ref4","doi-asserted-by":"crossref","first-page":"e14035","DOI":"10.1111\/jsr.14035","article-title":"The European insomnia guideline: An update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"key":"2025120408275253600_ref5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/0278-6133.25.1.3","article-title":"Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age","volume":"25","author":"Irwin","year":"2006","journal-title":"Health Psychol"},{"key":"2025120408275253600_ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smrv.2017.02.001","article-title":"Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis","volume":"38","author":"Van Straten","year":"2018","journal-title":"Sleep Med Rev"},{"key":"2025120408275253600_ref7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/10398562221118516","article-title":"Efficacy of cognitive behavioral therapy for insomnia (CBT-I) in older adults with insomnia: A systematic review and meta-analysis","volume":"30","author":"Huang","year":"2022","journal-title":"Australas Psychiatry"},{"key":"2025120408275253600_ref8","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"2025120408275253600_ref9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: Version 3","volume":"14","author":"O\u2019Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"2025120408275253600_ref10","doi-asserted-by":"publisher","first-page":"372.e1","DOI":"10.1016\/j.jamda.2017.12.099","article-title":"Fall-risk-increasing drugs: A systematic review and meta-analysis: III. Others","volume":"19","author":"Seppala","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"2025120408275253600_ref11","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: Prospective population based study","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"2025120408275253600_ref12","doi-asserted-by":"crossref","first-page":"e0174730","DOI":"10.1371\/journal.pone.0174730","article-title":"Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis","volume":"12","author":"Donnelly","year":"2017","journal-title":"PLoS One"},{"key":"2025120408275253600_ref13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12877-022-03165-6","article-title":"Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines","volume":"22","author":"Amari","year":"2022","journal-title":"BMC Geriatr"},{"key":"2025120408275253600_ref14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1183\/09031936.00008014","article-title":"Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD","volume":"44","author":"Vozoris","year":"2014","journal-title":"Eur Respir J"},{"key":"2025120408275253600_ref15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/phar.2170","article-title":"Association between development of dementia and use of benzodiazepines: A systematic review and meta-analysis","volume":"38","author":"Lucchetta","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2025120408275253600_ref16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00002512-200320110-00004","article-title":"The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: A Pharmo study","volume":"20","author":"Panneman","year":"2003","journal-title":"Drugs Aging"},{"key":"2025120408275253600_ref17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12877-024-04742-7","article-title":"Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries","volume":"24","author":"Luka\u010di\u0161inov\u00e1","year":"2024","journal-title":"BMC Geriatr"},{"key":"2025120408275253600_ref18","doi-asserted-by":"crossref","first-page":"zsad124","DOI":"10.1093\/sleep\/zsad124","article-title":"Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: A sales data analysis","volume":"46","author":"Ma","year":"2023","journal-title":"Sleep"},{"key":"2025120408275253600_ref19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40266-023-01029-1","article-title":"Benzodiazepine receptor agonists use and cessation among multimorbid older adults with polypharmacy: Secondary analysis from the OPERAM trial","volume":"40","author":"Sibille","year":"2023","journal-title":"Drugs Aging"},{"key":"2025120408275253600_ref20","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/jgs.16751","article-title":"Benzodiazepine use and deprescribing in Belgian nursing homes: Results from the COME-ON study","volume":"68","author":"Evrard","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2025120408275253600_ref21","doi-asserted-by":"crossref","first-page":"e031156","DOI":"10.1136\/bmjopen-2019-031156","article-title":"Patterns of benzodiazepine prescription among older adults in Switzerland: A cross-sectional analysis of claims data","volume":"10","author":"Luta","year":"2020","journal-title":"BMJ Open"},{"key":"2025120408275253600_ref22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","article-title":"Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: A systematic review of qualitative and quantitative studies using the theoretical domains framework","volume":"17","author":"Evrard","year":"2022","journal-title":"Implement Sci"},{"key":"2025120408275253600_ref23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/metabo11040254","article-title":"The barriers and facilitators of different stakeholders when deprescribing benzodiazepine receptor agonists in older patients\u2014A systematic review","volume":"11","author":"Rasmussen","year":"2021","journal-title":"Metabolites"},{"key":"2025120408275253600_ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40271-016-0182-z","article-title":"A systematic review and meta-synthesis of patients\u2019 experiences and perceptions of seeking and using benzodiazepines and Z-drugs: Towards safer prescribing","volume":"10","author":"Sirdifield","year":"2017","journal-title":"Patient"},{"key":"2025120408275253600_ref25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/gerona\/glab222","article-title":"Consumer attitudes towards deprescribing: A systematic review and meta-analysis","volume":"77","author":"Weir","year":"2022","journal-title":"J Gerontol Series A"},{"key":"2025120408275253600_ref26","doi-asserted-by":"crossref","first-page":"e2459883","DOI":"10.1001\/jamanetworkopen.2024.59883","article-title":"Barriers to deprescribing benzodiazepines in older adults in a survey of European physicians","volume":"8","author":"Shapoval","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2025120408275253600_ref27","doi-asserted-by":"publisher","DOI":"10.22541\/au.174420655.50928069\/v1","article-title":"Barriers to supporting deprescribing benzodiazepines in older adults: A survey of European non-physician healthcare professionals","author":"Shapoval","year":"2025;137:70100"},{"key":"2025120408275253600_ref28","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","article-title":"A consensus-based checklist for reporting of survey studies (CROSS)","volume":"36","author":"Sharma","year":"2021","journal-title":"J Gen Intern Med"},{"key":"2025120408275253600_ref29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"Von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2025120408275253600_ref30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13012-019-0951-x","article-title":"Action, actor, context, target, time (AACTT): A framework for specifying behaviour","volume":"14","author":"Presseau","year":"2019","journal-title":"Implement Sci"},{"key":"2025120408275253600_ref31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1748-5908-7-37","article-title":"Validation of the theoretical domains framework for use in behaviour change and implementation research","volume":"7","author":"Cane","year":"2012","journal-title":"Implement Sci"},{"key":"2025120408275253600_ref32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the theoretical domains framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"key":"2025120408275253600_ref33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40266-016-0410-1","article-title":"Development and validation of the revised patients\u2019 attitudes towards deprescribing (rPATD) questionnaire: Versions for older adults and caregivers","volume":"33","author":"Reeve","year":"2016","journal-title":"Drugs Aging"},{"key":"2025120408275253600_ref34","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.sapharm.2023.05.010","article-title":"Adaptation and validation of the revised patients\u2019 attitudes towards deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists","volume":"19","author":"P\u00e9tein","year":"2023","journal-title":"Res Social Adm Pharm"},{"key":"2025120408275253600_ref35","first-page":"S1551741123004679","article-title":"Development and validation of a theory-based questionnaire examining barriers and facilitators to discontinuing long-term benzodiazepine receptor agonist use","author":"Lynch","year":"2023","journal-title":"Res Soc Adm Pharm"},{"key":"2025120408275253600_ref36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/sja.SJA_203_17","article-title":"Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine","volume":"11","author":"Tsang","year":"2017","journal-title":"Saudi J Anaesth"},{"key":"2025120408275253600_ref37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/0895-4356(93)90142-N","article-title":"Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines","volume":"46","author":"Guillemin","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"2025120408275253600_ref38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40780-023-00325-7","article-title":"Analysis of patients\u2019 thoughts and background factors influencing attitudes toward deprescribing: Interviews to obtain hints for highly satisfying and valid prescriptions","volume":"9","author":"Arai","year":"2023","journal-title":"J Pharm Health Care Sci"},{"key":"2025120408275253600_ref39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/bmj.38551.410012.06","article-title":"Appropriateness of use of medicines in elderly inpatients: Qualitative study","volume":"331","author":"Spinewine","year":"2005","journal-title":"BMJ"},{"key":"2025120408275253600_ref40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/hex.13392","article-title":"\u201cI just thought that it was such an impossible thing\u201d: A qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the theoretical domains framework","volume":"25","author":"Lynch","year":"2022","journal-title":"Health Expect"},{"key":"2025120408275253600_ref41","doi-asserted-by":"crossref","first-page":"2424013","DOI":"10.1080\/17482631.2024.2424013","article-title":"\u2018I haven\u2019t discussed anything with anyone\u2019: Lived experience of long-term users of benzodiazepine receptor agonists regarding their treatment for substance use disorder","volume":"19","author":"Van Ngoc","year":"2024","journal-title":"Int J Qual Stud Health Well Being"},{"key":"2025120408275253600_ref42","doi-asserted-by":"crossref","first-page":"e13962","DOI":"10.1111\/hex.13962","article-title":"\u2018We need more support and doctors that understand the process of tapering \u2026\u2019: A content analysis of free-text responses to a questionnaire on discontinuing long-term benzodiazepine receptor agonist use","volume":"27","author":"Lynch","year":"2024","journal-title":"Health Expect"},{"key":"2025120408275253600_ref43","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s11096-022-01419-2","article-title":"Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: A qualitative study","volume":"44","author":"Rowe","year":"2022","journal-title":"Int J Clin Pharmacol"},{"key":"2025120408275253600_ref44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12877-019-1102-6","article-title":"Family involvement in managing medications of older patients across transitions of care: A systematic review","volume":"19","author":"Manias","year":"2019","journal-title":"BMC Geriatr"},{"key":"2025120408275253600_ref45","doi-asserted-by":"crossref","first-page":"e14282","DOI":"10.1111\/jsr.14282","article-title":"Sleep should not be this difficult: An interpretive descriptive study of older adults\u2019 perspectives on behaviour change elements in Sleepwell and experiences with benzodiazepine discontinuation","volume":"34","author":"Katmeh","year":"2025","journal-title":"J Sleep Res"},{"key":"2025120408275253600_ref46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1207\/s15327957pspr0803_1","article-title":"Reflective and impulsive determinants of social behavior","volume":"8","author":"Strack","year":"2004","journal-title":"Personal Soc Psychol Rev"},{"key":"2025120408275253600_ref47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.psych.59.103006.093629","article-title":"Dual-processing accounts of reasoning, judgment, and social cognition","volume":"59","author":"Evans","year":"2008","journal-title":"Annu Rev Psychol"},{"key":"2025120408275253600_ref48","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025120408275253600_ref49","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: The D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"key":"2025120408275253600_ref50","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamapsychiatry.2024.2731","article-title":"Patient self-guided interventions to reduce sedative use and improve sleep: The YAWNS NB randomized clinical trial","volume":"81","author":"Gardner","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"2025120408275253600_ref51","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.sapharm.2025.05.002","article-title":"Equipping physicians for benzodiazepine receptor agonists deprescription in older adults: Theory-based development of the BE-SAFE intervention","volume":"21","author":"Sibille","year":"2025","journal-title":"Res Soc Adm Pharm"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/12\/afaf342\/65738346\/afaf342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/12\/afaf342\/65738346\/afaf342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T13:28:03Z","timestamp":1764854883000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afaf342\/8365009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afaf342","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,28]]},"article-number":"afaf342"}}